The Chemours CC
$10.88 −$0.92 (-7.80%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $11.20 +2.94%
Open$11.67
Prev close$11.80
Day range$10.83 – $11.92
Volume3.14M
Market cap$1.64B
P/E (TTM)–
Dividend yield3.22%
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$1.54B+3.0% YoY
Operating profit$230.00M+187.5% YoY
Net profit$196.00M+326.1% YoY
Diluted EPS$1.29+316.1% YoY
Free cash flow$98.00M-6.7% YoY
Operating cash flow$149.00M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin15.1%
Operating margin0.8%
Net margin-2.6%
Return on equity-68.0%
Return on assets-2.1%
Return on invested capital0.2%
Current ratio1.81
Liabilities / assets97.9%
Cash & investments$698.00M
Total debt$4.03B
Net cash (debt)-$3.33B
Free cash flow / sales3.6%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $1.54B | $1.59B | $1.38B | $5.81B | $1.33B |
| Total Operating Revenue | $1.54B | $1.59B | $1.38B | $5.81B | $1.33B |
| Cost of Revenue | $1.31B | $1.31B | $1.17B | $4.91B | $1.17B |
| Gross Profit | $231.00M | $286.00M | $212.00M | $902.00M | $156.00M |
| Operating Expense | $1.00M | $496.00M | $173.00M | $930.00M | $161.00M |
| Selling and Admin Expenses | -$25.00M | $469.00M | $147.00M | $799.00M | $130.00M |
| Research & Development | $24.00M | $27.00M | $26.00M | $108.00M | $27.00M |
| Other Operating Expenses | $2.00M | – | – | $23.00M | $4.00M |
| Operating Profit | $230.00M | -$210.00M | $39.00M | -$28.00M | -$5.00M |
| Net Non-Operating Interest Income (Expense) | -$69.00M | -$68.00M | -$69.00M | -$269.00M | -$68.00M |
| Non-Operating Interest Expense | $69.00M | $68.00M | $69.00M | $269.00M | $68.00M |
| Other Income (Expense) | $61.00M | $277.00M | $8.00M | $20.00M | $6.00M |
| Gain on Sale of Security | -$4.00M | -$1.00M | $1.00M | -$11.00M | -$4.00M |
| Earnings from Equity Interest | $11.00M | $9.00M | $8.00M | $35.00M | $8.00M |
| Special Income (Charges) | $49.00M | $261.00M | -$22.00M | -$33.00M | -$5.00M |
| -Less:Restructuring and Mergern & Acquisition | $1.00M | $3.00M | $13.00M | $36.00M | $0.00 |
| -Gain on Sale of Property/Plant/Equipment | $50.00M | $266.00M | $0.00 | $8.00M | $0.00 |
| Other Non-Operating Income (Expenses) | $5.00M | $8.00M | $21.00M | $29.00M | $7.00M |
| Pretax Profit | $222.00M | -$1.00M | -$22.00M | -$277.00M | -$67.00M |
| Tax | $26.00M | $273.00M | $7.00M | $109.00M | -$19.00M |
| Net Profit | $196.00M | -$274.00M | -$29.00M | -$386.00M | -$48.00M |
| Profit from Continuing Operations | $196.00M | -$274.00M | -$29.00M | -$386.00M | -$48.00M |
| Minority Interests | $0.00 | $0.00 | – | $0.00 | -$1.00M |
| Net Income to Parent Company | $196.00M | -$274.00M | -$29.00M | -$386.00M | -$47.00M |
| Net Income to Common Stockholders | $196.00M | -$274.00M | -$29.00M | -$386.00M | -$47.00M |
| Basic EPS | $1.29 | -$1.81 | -$0.19 | -$2.57 | -$0.31 |
| Diluted EPS | $1.29 | -$1.81 | -$0.19 | -$2.57 | -$0.31 |
| Dividend Per Share | $0.09 | $0.09 | $0.09 | $0.51 | $0.09 |
| -Less:Other Special Charges | – | $2.00M | $9.00M | $5.00M | – |
| -Less:Impairment of Capital Assets | – | – | – | $0.00 | $0.00 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $7.29B | $7.15B | $7.27B | $7.38B | $7.38B |
| Total Current Assets | $3.22B | $3.09B | $2.93B | $3.00B | $3.00B |
| Cash and Cash Equivalents & Short-Term Investments | $698.00M | $671.00M | $563.00M | $670.00M | $670.00M |
| -Cash and Cash Equivalents | $698.00M | $671.00M | $563.00M | $670.00M | $670.00M |
| Receivables | $922.00M | $907.00M | $759.00M | $679.00M | $679.00M |
| -Accounts Receivable | $765.00M | $773.00M | $645.00M | $562.00M | $562.00M |
| -Taxes Receivable | $130.00M | $111.00M | $91.00M | $96.00M | $96.00M |
| -Other Receivables | $27.00M | $23.00M | $23.00M | $21.00M | $21.00M |
| Inventory | $1.48B | $1.45B | $1.54B | $1.57B | $1.57B |
| Restricted Cash | $41.00M | $0.00 | $0.00 | $2.00M | $2.00M |
| Other Current Assets | $82.00M | $63.00M | $69.00M | $80.00M | $80.00M |
| Total Non-Current Assets | $4.07B | $4.06B | $4.34B | $4.38B | $4.38B |
| Net PPE | $3.29B | $3.30B | $3.31B | $3.35B | $3.35B |
| -Gross PPE | $10.28B | $10.26B | $10.20B | $10.19B | $10.19B |
| -Accumulated Depreciation | -$6.99B | -$6.97B | -$6.88B | -$6.84B | -$6.84B |
| Investments and Advances | $184.00M | $170.00M | $166.00M | $160.00M | $160.00M |
| -Long Term Equity Investment | $184.00M | $170.00M | $166.00M | $160.00M | $160.00M |
| Goodwill and Other Intangible Assets | $48.00M | $48.00M | $48.00M | $48.00M | $48.00M |
| -Goodwill | $46.00M | $46.00M | $46.00M | $46.00M | $46.00M |
| -Other Intangible Assets | $2.00M | $2.00M | $2.00M | $2.00M | $2.00M |
| Defined Pension Benefit | $145.00M | $140.00M | $142.00M | $142.00M | $142.00M |
| Non-Current Deferred Assets | $53.00M | $46.00M | $258.00M | $254.00M | $254.00M |
| Other Non-Current Assets | $358.00M | $354.00M | $411.00M | $428.00M | $428.00M |
| Total Liabilities | $7.14B | $7.20B | $7.05B | $7.13B | $7.13B |
| Total Current Liabilities | $1.78B | $1.86B | $1.61B | $1.69B | $1.69B |
| Payables | $1.00B | $944.00M | $898.00M | $964.00M | $964.00M |
| -Accounts Payable | $956.00M | $907.00M | $863.00M | $929.00M | $929.00M |
| -Total Tax Payable | $47.00M | $37.00M | $35.00M | $35.00M | $35.00M |
| Current Accrued Expenses | $440.00M | $605.00M | $380.00M | $425.00M | $425.00M |
| Short-Term Debt and Capital Lease Obligation | $116.00M | $91.00M | $99.00M | $104.00M | $104.00M |
| -Current Debt | $50.00M | $34.00M | $37.00M | $42.00M | $42.00M |
| -Current Capital Lease Obligation | $66.00M | $57.00M | $62.00M | $62.00M | $62.00M |
| Current Provisions | $131.00M | $138.00M | $110.00M | $97.00M | $97.00M |
| Total Non-Current Liabilities | $5.36B | $5.34B | $5.44B | $5.45B | $5.45B |
| Non-Current Accrued Expenses | $362.00M | $301.00M | $315.00M | $317.00M | $317.00M |
| Long Term Debt and Capital Lease Obligation | $3.98B | $4.03B | $4.29B | $4.29B | $4.29B |
| -Long Term Debt | $3.78B | $3.84B | $4.10B | $4.10B | $4.10B |
| -Long Term Capital Lease Obligation | $192.00M | $191.00M | $192.00M | $191.00M | $191.00M |
| Non-Current Liabilities | $780.00M | $764.00M | $615.00M | $621.00M | $621.00M |
| Non-Current Deferred Liabilities | $65.00M | $64.00M | $40.00M | $37.00M | $37.00M |
| Employee Benefits | $55.00M | $56.00M | $56.00M | $58.00M | $58.00M |
| Other Non-Current Liabilities | $123.00M | $123.00M | $124.00M | $122.00M | $122.00M |
| Total Equity | $156.00M | -$48.00M | $216.00M | $251.00M | $251.00M |
| Stockholders' Equity | $155.00M | -$49.00M | $215.00M | $250.00M | $250.00M |
| Capital Stock | $2.00M | $2.00M | $2.00M | $2.00M | $2.00M |
| -Common Stock | $2.00M | $2.00M | $2.00M | $2.00M | $2.00M |
| Additional Paid-In Capital | $1.09B | $1.09B | $1.08B | $1.07B | $1.07B |
| Retained Earnings | $1.07B | $891.00M | $1.18B | $1.22B | $1.22B |
| Less: Treasury Stock | -$1.80B | -$1.80B | -$1.80B | -$1.80B | -$1.80B |
| Gains/Losses Not Affecting Retained Earnings | -$211.00M | -$229.00M | -$244.00M | -$244.00M | -$244.00M |
| Minority Interests | $1.00M | $1.00M | $1.00M | $1.00M | $1.00M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $149.00M | $158.00M | -$44.00M | $264.00M | $137.00M |
| Net cash flow from continuing operations | $149.00M | $158.00M | -$44.00M | $264.00M | $137.00M |
| Net Income from Continuing Operations | $196.00M | -$274.00M | -$29.00M | -$386.00M | -$48.00M |
| Gain/Loss from Continuing Operations | -$61.00M | -$269.00M | $3.00M | -$12.00M | $20.00M |
| Depreciation & Depletion & Amortization | $80.00M | $80.00M | $79.00M | $340.00M | $81.00M |
| Deferred Tax | -$10.00M | $249.00M | -$11.00M | $64.00M | -$18.00M |
| Other Non-Cash Items | $8.00M | $7.00M | -$11.00M | $59.00M | $6.00M |
| Change in Working Capital | -$68.00M | $358.00M | -$82.00M | $178.00M | $92.00M |
| -Change in Receivables | -$5.00M | -$141.00M | -$77.00M | $106.00M | $269.00M |
| -Change in Inventory | -$38.00M | $82.00M | $32.00M | -$106.00M | -$30.00M |
| -Change in Payables and Accrued Expense | $44.00M | $46.00M | -$58.00M | -$165.00M | -$86.00M |
| -Change in Other Current Assets | $12.00M | $36.00M | $17.00M | $66.00M | -$4.00M |
| -Change in Other Current Liabilities | -$81.00M | $335.00M | $4.00M | $277.00M | -$57.00M |
| Net cash flow from investing | -$7.00M | $239.00M | -$44.00M | -$206.00M | -$43.00M |
| Net Cash Flow from Continuing Investing Activities | -$7.00M | $239.00M | -$44.00M | -$206.00M | -$43.00M |
| Net PPE Purchase and Sale | -$51.00M | -$44.00M | -$49.00M | -$213.00M | -$45.00M |
| Net Investment Purchase and Sale | -$1.00M | -$4.00M | -$3.00M | -$1.00M | $2.00M |
| Net Other Investing Changes | $45.00M | $287.00M | $8.00M | $8.00M | $0.00 |
| Financing Cash Flow | -$63.00M | -$289.00M | -$19.00M | -$126.00M | -$37.00M |
| Net Cash Flow from Continuing Financing Activities | -$63.00M | -$289.00M | -$19.00M | -$126.00M | -$37.00M |
| Net Issuance Payments Of Debt | -$66.00M | -$268.00M | -$6.00M | -$61.00M | -$19.00M |
| Cash Dividends Paid | -$13.00M | -$13.00M | -$13.00M | -$78.00M | -$15.00M |
| Proceeds from Stock Option Exercised | $0.00 | $1.00M | $2.00M | $0.00 | $0.00 |
| Net Other Financing Charges | $48.00M | -$25.00M | -$18.00M | $13.00M | -$3.00M |
| Ending Cash Balance | $801.00M | $723.00M | $615.00M | $724.00M | $724.00M |
| Net Change in Cash | $79.00M | $108.00M | -$107.00M | -$68.00M | $57.00M |
| Beginning Cash Balance | $723.00M | $615.00M | $724.00M | $763.00M | $665.00M |
| Effect of Exchange Rate Changes | -$1.00M | $0.00 | -$2.00M | $29.00M | $2.00M |
| Free Cash Flow | $98.00M | $114.00M | -$93.00M | $51.00M | $92.00M |
| Net Common Stock Issuance | – | $16.00M | $16.00M | $0.00 | – |
No comments yet — be the first to weigh in on CC.
Sign in to join the discussion.